Transcranial sonography and cognitive dysfunction in Parkinson’s disease
Objective: To evaluate the role of transcranial sonography (TCS) in discriminating between Parkinson's disease (PD) patients with normal cognition (PDNC), mild cognitive impairment (PD-MCI) and…Bradykinesia, low monthly income and current employment are associated with depression in patients with Parkinson’s disease: Results of a study from Sri Lanka
Objective: The objectives of this cross sectinal studies was to a) estimate the prevalence of depression and b) identify the associations for depression in a…Factors related to psychotic symptoms in patients with Parkinson’s disease
Objective: The aim of this study was to compare clinical characteristics in Parkinson's disease (PD) with psychosis (PDP) versus PD without psychosis (PDnP) and evaluate…Blinded video assessment of subtle Parkinsonian signs in PREDICT-PD participants
Objective: To determine whether risk estimates calculated in PREDICT-PD are associated with objective motor features on clinical examination. Background: PREDICT-PD aims to identify a group…The International Parkinson and Movement Disorder Society – non-motor rating scale (MDS-NMS): Results from the cognitive pre-testing and phases 1 and 2 of an international validation
Objective: To revise the Non-Motor Sumptom Scale (NMSS) and develop a new up to date version, the MDS-NMS, a project commissioned by the International Parkinson…Self-perception of vocal handicap in Parkinson’s disease
Objective: The objective of this study was to evaluate self-perception of vocal handicap in individuals with Parkinson's disease at various stages of diagnosis. Background: The…Biochemical features of lipids spectrum in blood in patients with Parkinson’s disease
Objective: To study characteristic of lipid levels in patients with PD. Background: Currently, there is no clear data about the features of lipid metabolism in…Dynamic prediction for multiple repeated measures and event time data: An application to Parkinson’s disease
Objective: To develop methods for model-based personalized dynamic prediction of future outcome measure trajectories and risks of target events for the Parkinson's disease patients. Background:…Effects of safinamide in patients with Parkinson’s disease measured by Parkinson’s KinetiGraphTM
Objective: To objectively evaluate the effects of Safinamide in patients with Parkinson's (PD) by using the Parkinson's KinetiGraphTM (PKG), a newly developed tool for graphically…Day case initiation of subcutaneous apomorphine in people with Parkinson’s disease: A retrospective analysis from a UK teaching hospital
Objective: To evaluate a cohort of people with Parkinson's disease (PD) who were initiated on subcutaneous apomorphine injections or continuous subcutaneous apomorphine infusions (CSAI) on…
- « Previous Page
- 1
- …
- 348
- 349
- 350
- 351
- 352
- …
- 388
- Next Page »